Half-year Report
Summary by AI BETAClose X
|
Condensed Consolidated Statement of Profit or Loss and other Comprehensive Income |
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
30 June 2025 |
|
30 June 2024 |
|
|
|
|
|
|
Shs'000 |
|
Shs'000 |
|
|
|
Sales |
|
|
1,511,260 |
|
1,175,166 |
|
|
|
Profit before fair value gain in non-current biological assets and income tax |
|
|
409,666 |
|
485,583 |
|
|
|
Fair value gain in non-current biological assets |
|
|
25,579 |
|
21,509 |
|
|
|
Profit before income tax |
|
|
435,245 |
|
507,092 |
|
|
|
Income tax expense |
|
|
(139,707 |
) |
(159,581 |
) |
|
|
Profit for the period |
|
|
295,538 |
|
347,511 |
|
|
|
Other Comprehensive Income |
|
|
- |
|
- |
|
|
|
Total comprehensive income |
|
|
295,538 |
|
347,511 |
|
|
|
|
|
|
Shs |
|
Shs |
|
|
|
Earnings per share (Shs): |
|
|
|
|
|
|
|
|
Basic and diluted earnings per ordinary share |
|
|
15.08 |
|
17.73 |
|
|
|
|
|
|
|
|
|
|
|
|
Condensed Consolidated Statement of Financial Position |
||||||||||
|
|
|
|
|
|
|
|
|
|
Audited |
|
|
|
|
|
|
|
30 June 2025 |
|
30 June 2024 |
|
31 Dec 2024 |
|
|
|
|
|
|
|
Shs'000 |
|
Shs'000 |
|
Shs'000 |
|
|
EQUITY |
|
|
|
|
|
|
|
|
|
|
|
Share capital |
|
|
|
|
98,000 |
|
98,000 |
|
98,000 |
|
|
Other reserves |
|
|
|
|
36,251 |
|
34,929 |
|
36,251 |
|
|
Retained earnings |
|
|
|
|
5,337,797 |
|
5,678,264 |
|
5,042,259 |
|
|
Proposed dividends |
|
|
|
|
- |
|
- |
|
156,800 |
|
|
Total equity |
|
|
|
|
5,472,048 |
|
5,811,193 |
|
5,333,310 |
|
|
Non-current liabilities |
|
|
|
|
1,303,861 |
|
1,244,674 |
|
1,267,964 |
|
|
|
|
|
|
|
6,775,909 |
|
7,055,867 |
|
6,601,274 |
|
|
REPRESENTED BY |
|
|
|
|
|
|
|
|
|
|
|
Non-current assets |
|
|
|
|
4,054,964 |
|
3,986,091 |
|
4,157,742 |
|
|
Cash assets excluding cash and bank balances |
2,243,123 |
|
3,456,440 |
|
1,651,215 |
|
||||
|
Cash and bank balances |
890,293 |
|
130,377 |
|
1,106,684 |
|
||||
|
Current liabilities |
|
|
|
|
(412,471 |
) |
(517,041 |
) |
(314,367 |
) |
|
Net working capital |
|
|
|
|
2,720,945 |
|
3,069,776 |
|
2,443,532 |
|
|
|
|
|
|
|
6,775,909 |
|
7,055,867 |
|
6,601,274 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Condensed Consolidated Statement of Cash flows |
|
|
|||||
|
|
|
|
30 June 2025 |
|
30 June 2024 |
|
|
|
|
|
|
Shs'000 |
|
Shs'000 |
|
|
|
Cash and cash equivalents at the beginning of the period |
|
|
1,106,684 |
|
1,408,131 |
|
|
|
Net cash used in operating activities |
|
|
11,871 |
|
(536,131 |
) |
|
|
Net cash used in investing activities |
|
|
(67,603 |
) |
(107,891 |
) |
|
|
Net cash used in financing activities |
|
|
(156,861 |
) |
(470,400 |
) |
|
|
Effect of exchange rate differences on cash and cash equivalents |
|
|
(3,798 |
) |
(163,332 |
) |
|
|
Decrease in cash and cash equivalents |
|
|
(216,391 |
) |
(1,277,754 |
) |
|
|
Cash and cash equivalents at the end of the period |
|
|
890,293 |
|
130,377 |
|
|
|
|
|
|
|
|
|
|
|
|
Condensed Consolidated Statement of Changes in Equity |
|
||||||||||
|
|
Share capital |
|
Other reserves |
|
Retained earnings |
|
Proposed dividends |
|
Total Equity |
|
|
|
|
Shs'000 |
|
Shs'000 |
|
Shs'000 |
|
Shs'000 |
|
Shs'000 |
|
|
|
As at 1 January 2025 |
98,000 |
|
36,251 |
|
5,042,259 |
|
156,800 |
|
5,333,310 |
|
|
|
Profit for the period |
- |
|
- |
|
295,538 |
|
- |
|
295,538 |
|
|
|
Dividends paid |
- |
|
- |
|
- |
|
(156,800 |
) |
(156,800 |
) |
|
|
As at 30 June 2025 |
98,000 |
|
36,251 |
|
5,337,797 |
|
- |
|
5,472,048 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 11 hours ago Johnson Matthey
- 13 hours ago Galliford Try
- 13 hours ago Galliford Try
- 13 hours ago Centrica
- 14 hours ago Smith & Nephew